Genome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans
Author Information
Author(s): Xu Deming, Jiang Bo, Ketela Troy, Lemieux Sebastien, Veillette Karynn, Martel Nick, Davison John, Sillaots Susan, Trosok Steve, Bachewich Catherine, Bussey Howard, Youngman Phil, Roemer Terry
Primary Institution: Center of Fungal Genetics, Merck Frosst Canada Ltd.
Hypothesis
Can chemically induced haploinsufficiency be used to identify the mechanism of action of antifungal agents in Candida albicans?
Conclusion
The study demonstrates that chemically induced haploinsufficiency profiles can effectively identify the mechanisms of action of various antifungal agents.
Supporting Evidence
- Candida albicans is responsible for approximately 50% of all human life-threatening nosocomial fungal infections.
- The study identified specific genes involved in the response to antifungal agents.
- Chemically induced haploinsufficiency was shown to be a useful method for drug discovery.
- Multiple FDA-approved antifungal drugs were tested for their mechanisms of action.
- The fitness test approach allows for a pathogen-focused strategy in antifungal drug discovery.
Takeaway
Researchers created a library of mutant yeast strains to see how they react to different antifungal drugs, helping to understand how these drugs work.
Methodology
The study involved constructing a library of 2,868 heterozygous deletion mutants and screening them with 35 compounds to assess their effects on growth and identify genetic interactions.
Potential Biases
Potential bias due to the reliance on heterozygous strains which may not represent all genetic variations.
Limitations
The study is biased towards identifying conserved genes and may not capture C. albicans specific genes due to the nature of the inhibitors used.
Participant Demographics
The study focused on the yeast species Candida albicans, particularly its diploid strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website